Develops, manufactures and markets a robust line of rapid diagnostic tests that address some of today's greatest healthcare challenges, including HIV and Hepatitis C.

Free
Message: NR after the bell...Sorry folks

I don't expect any more news until after this deal closes. It seems that Y A Global is not ashamed to sop up our cheap shares, clearly as a major venture capital investment organization they have they have their sights on a return. I am feeling more confident about Medmira all the time.


~~Dimar

Share
New Message
Please login to post a reply